Evidence map›Paper›PMID 19225158›Full record

ArticleMolecular biology of the cell2009

Mislocalized scaffolding by the Na-H exchanger NHE1 dominantly inhibits fibronectin production and TGF-beta activation.

Anastasios Karydis, Maite Jimenez-Vidal, Sheryl P Denker, Diane L Barber

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Acid-base transporters in the context of tumor heterogeneity.Pflugers Archiv : European journal of physiology · 2024
    Review
  3. Review
  4. Article
  5. Roles of the NaInternational journal of molecular sciences · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. A human MAP kinase interactome.Nature methods · 2010
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anastasios KarydisDepartment of Cell and Tissue Biology, University of California, San Francisco, 94143, USA.
Maite Jimenez-Vidal
Sheryl P Denker
Diane L Barber
University of California, San Francisco · US

Funding

MECHANISMS OF RECEPTOR-REGULATED NA+/H+ EXCHANGER01GM047413 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARBER, DIANE L · 1993 to 2014
$4.2M
PROGRAM IN CRANIOFACIAL &SKELETAL BIOC06RR016490 · NCRR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BERTOLAMI, CHARLES N · 2001 to 2001
$2.0M
NCRR NIH HHS C06 RR016490NCRR NIH HHS C06 RR16490NIGMS NIH HHS GM47413NIGMS NIH HHS R01 GM047413
6 · The paper itself

Abstract

Secretion and assembly of the extracellular matrix protein fibronectin regulates a number of normal cell and tissue functions and is dysregulated in disease states such as fibrosis, diabetes, and cancer. We found that mislocalized scaffolding by the plasma membrane Na-H exchanger NHE1 suppresses fibronectin expression, secretion, and assembly. In fibroblasts, wild-type NHE1 localizes to the distal margin of membrane protrusions or lamellipodia but a mutant NHE1-KRA2 lacking binding sites for PI(4,5)P2 and the ERM proteins ezrin, radixin, and moesin is mislocalized and found uniformly along the plasma membrane. Although NHE1 regulates intracellular pH homeostasis, fibronectin production is not regulated by changes in intracellular pH, nor is it attenuated in NHE1-deficient cells, indicating fibronectin expression is independent of NHE1 activity. However, fibronectin production is nearly absent in cells expressing NHE1-KRA2 because scaffolding by NHE1 is mislocalized. Additionally, secretion of active but not latent TGF-beta is reduced and exogenous TGF-beta restores fibronectin secretion and assembly. Our data indicate that scaffolding by NHE1-KRA2 dominantly suppresses fibronectin synthesis and TGF-beta activation, and they suggest that NHE1-KRA2 can be used for obtaining a mechanistic understanding of how fibronectin production is regulated and speculatively for therapeutic control of dysregulated production in pathological conditions.

Indexed as

AnimalsCell Surface ExtensionsCricetinaeEarly Growth Response Protein 1FibroblastsFibronectinsFocal AdhesionsHumansIntegrin beta1Protein BindingProtein TransportProtonsSignal TransductionSodium-Hydrogen ExchangersTranscription, GeneticTransforming Growth Factor betaEarly Growth Response Protein 1FibronectinsIntegrin beta1ProtonsSodium-Hydrogen ExchangersTransforming Growth Factor beta

Identifiers

PMID19225158
PMCPMC2669038
OpenAlexW2149146087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.